協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/03/01 | 2,927.5 | 2,974.5 | 2,925.5 | 2,952.5 | -19 | -0.6% | 1,011,400 |
2024/02/29 | 2,946 | 2,983 | 2,927 | 2,971.5 | +22 | +0.7% | 1,655,100 |
2024/02/28 | 2,933 | 2,983.5 | 2,926 | 2,949.5 | +0.5 | ±0% | 1,065,000 |
2024/02/27 | 2,892 | 2,956 | 2,892 | 2,949 | +32 | +1.1% | 1,207,600 |
2024/02/26 | 2,903 | 2,947 | 2,900 | 2,917 | +43 | +1.5% | 1,303,300 |
2024/02/22 | 2,867.5 | 2,889 | 2,822.5 | 2,874 | -5.5 | -0.2% | 1,634,800 |
2024/02/21 | 2,902 | 2,916.5 | 2,875.5 | 2,879.5 | -15 | -0.5% | 926,700 |
2024/02/20 | 2,858 | 2,907.5 | 2,855 | 2,894.5 | +36.5 | +1.3% | 1,003,200 |
2024/02/19 | 2,880.5 | 2,888 | 2,833.5 | 2,858 | -29 | -1% | 872,500 |
2024/02/16 | 2,830 | 2,900 | 2,819 | 2,887 | +87 | +3.1% | 1,766,400 |
2024/02/15 | 2,810 | 2,842 | 2,797 | 2,800 | +20 | +0.7% | 1,318,900 |
2024/02/14 | 2,781.5 | 2,821 | 2,730 | 2,780 | -44.5 | -1.6% | 1,786,600 |
2024/02/13 | 2,763 | 2,835 | 2,737 | 2,824.5 | +61.5 | +2.2% | 2,583,300 |
2024/02/09 | 2,727.5 | 2,769 | 2,691 | 2,763 | +55.5 | +2% | 2,868,000 |
2024/02/08 | 2,618 | 2,723.5 | 2,568 | 2,707.5 | +439.5 | +19.4% | 6,675,300 |
2024/02/07 | 2,320 | 2,320 | 2,266.5 | 2,268 | -54 | -2.3% | 1,239,000 |
2024/02/06 | 2,314 | 2,326 | 2,285 | 2,322 | +9.5 | +0.4% | 913,600 |
2024/02/05 | 2,315 | 2,335 | 2,312 | 2,312.5 | -1 | ±0% | 705,900 |
2024/02/02 | 2,317.5 | 2,335.5 | 2,311.5 | 2,313.5 | +3.5 | +0.2% | 659,100 |
2024/02/01 | 2,315 | 2,318.5 | 2,288.5 | 2,310 | -23.5 | -1% | 700,700 |
2024/01/31 | 2,286 | 2,342 | 2,284 | 2,333.5 | +29 | +1.3% | 1,343,400 |
2024/01/30 | 2,327 | 2,344 | 2,304.5 | 2,304.5 | -22 | -0.9% | 853,400 |
2024/01/29 | 2,345.5 | 2,346 | 2,319.5 | 2,326.5 | -12 | -0.5% | 1,022,100 |
2024/01/26 | 2,344.5 | 2,352 | 2,337 | 2,338.5 | -15 | -0.6% | 717,900 |
2024/01/25 | 2,365.5 | 2,388.5 | 2,340 | 2,353.5 | -23 | -1% | 786,700 |
2024/01/24 | 2,400 | 2,417 | 2,374 | 2,376.5 | -9 | -0.4% | 841,400 |
2024/01/23 | 2,367 | 2,397.5 | 2,367 | 2,385.5 | +22 | +0.9% | 833,300 |
2024/01/22 | 2,340.5 | 2,369 | 2,336 | 2,363.5 | +20 | +0.9% | 755,000 |
2024/01/19 | 2,364 | 2,369.5 | 2,331.5 | 2,343.5 | -33.5 | -1.4% | 1,144,400 |
2024/01/18 | 2,376.5 | 2,390.5 | 2,361 | 2,377 | -14 | -0.6% | 774,500 |
2024/01/17 | 2,422 | 2,427 | 2,380.5 | 2,391 | -34.5 | -1.4% | 1,166,700 |
2024/01/16 | 2,443 | 2,455.5 | 2,421 | 2,425.5 | -37 | -1.5% | 757,400 |
2024/01/15 | 2,478 | 2,482 | 2,442 | 2,462.5 | -23.5 | -0.9% | 1,001,900 |
2024/01/12 | 2,576 | 2,576 | 2,473 | 2,486 | -42.5 | -1.7% | 1,548,900 |
2024/01/11 | 2,541 | 2,557 | 2,517 | 2,528.5 | -4.5 | -0.2% | 1,023,000 |
2024/01/10 | 2,494 | 2,537 | 2,487.5 | 2,533 | +61.5 | +2.5% | 1,246,700 |
2024/01/09 | 2,426 | 2,484 | 2,425 | 2,471.5 | +57 | +2.4% | 1,107,300 |
2024/01/05 | 2,451 | 2,451 | 2,414.5 | 2,414.5 | -20 | -0.8% | 808,200 |
2024/01/04 | 2,390 | 2,437 | 2,366.5 | 2,434.5 | +64.5 | +2.7% | 925,700 |
2023/12/29 | 2,366.5 | 2,373 | 2,356.5 | 2,370 | +5 | +0.2% | 650,700 |
2023/12/28 | 2,333 | 2,365 | 2,330.5 | 2,365 | -18 | -0.8% | 618,000 |
2023/12/27 | 2,370.5 | 2,392 | 2,360 | 2,383 | +28 | +1.2% | 1,038,400 |
2023/12/26 | 2,355.5 | 2,368.5 | 2,348.5 | 2,355 | +4.5 | +0.2% | 559,100 |
2023/12/25 | 2,368 | 2,380 | 2,350.5 | 2,350.5 | +9.5 | +0.4% | 384,300 |
2023/12/22 | 2,333.5 | 2,348.5 | 2,325 | 2,341 | +20 | +0.9% | 699,000 |
2023/12/21 | 2,370.5 | 2,379 | 2,320 | 2,321 | -63 | -2.6% | 946,100 |
2023/12/20 | 2,381.5 | 2,419 | 2,378 | 2,384 | +5 | +0.2% | 671,500 |
2023/12/19 | 2,391 | 2,395.5 | 2,353 | 2,379 | -9.5 | -0.4% | 583,100 |
2023/12/18 | 2,385.5 | 2,407 | 2,379.5 | 2,388.5 | -23.5 | -1% | 582,500 |
2023/12/15 | 2,435 | 2,441.5 | 2,397.5 | 2,412 | -32.5 | -1.3% | 1,210,000 |
51~
100
件表示中 / 3456件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 262,500円 | +7.0% | -12.6% | 2.21% | 22.20倍 | 1.67倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 713,000円 | +4.6% | +0.9% | 2.38% | 12.40倍 | 1.63倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 670,100円 | +1.7% | -2.9% | 2.39% | 44.73倍 | 2.20倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 226,700円 | -10.5% | -24.9% | 3.53% | 11.70倍 | 1.34倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 286,700円 | +10.8% | +3.7% | 1.05% | 20.44倍 | 2.66倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム